Azathioprine and interferon β-1b treatment in relapsing-remitting multiple sclerosis [8]

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 3, 2001, Pages 413-414

  Milanese, C ^a   La Mantia, L ^a   Salmaggi, A ^a   Caputo, D ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INTERFERON BETA SERINE;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; LETTER; MALE; MULTIPLE SCLEROSIS; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECURRENT DISEASE; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0035082473     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.3.413     Document Type: Letter

References (5)

1. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
2. Overview of azathioprine treatment in multiple sclerosis
3. Validation of Italian multiple sclerosis quality of life 54 questionnaire
4. The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TwiST analysis
5. Treatment with interferon beta-1b improves quality of life in multiple sclerosis